The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/23221
StudyName: Eligibility Lymphoma, B-Cell NCT00515138
Date of export from the portal: 02.07.2020
Date of Upload / last change: 29.06.2017
License: Creative Commons BY 4.0

----

Description: 
A Pilot Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide (RICE) Plus Bortezomib (Velcade) in a Dose-Escalating Fashion for Patients With Relapsed or Primary Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma Who Are Candidates for Autologous Stem Cell Transplant; ODM derived from: https://clinicaltrials.gov/show/NCT00515138
